Upper gastrointestinal endoscopy: a prospective randomized study comparing continuous supplemental oxygen via the nasal or oral route.
We have examined the efficacy of supplemental oxygen in preventing episodes of significant arterial desaturation (SpO2 less than 90%) during upper gastrointestinal endoscopy. We have compared the effects of 2 liters.min-1 of oxygen given orally via the bite-guard with the same flow rate via nasal cannulas and have also examined the effects of pre-oxygenation. Results of this study at a flow rate of 2 liters.min-1 have been compared with previously published results at a flow rate of 3 liters.min-1. Although in this study fewer episodes of desaturation were seen in the orally supplemented group compared with the nasal group, the difference observed was not statistically significant. Pre-oxygenation significantly reduced episodes of desaturation (SpO2 less than 90%, p less than 0.01) and prevented SpO2 falls below 85% in all patients studied. Supplemental oxygen given at a rate of 2 liters.min-1 was as effective as that given at a rate of 3 liters.min-1 in preventing significant desaturation, as previously defined, during the procedure. We therefore recommend the use of supplemental oxygen at a flow rate of 2 liters.min-1 in all high risk patients and conclude that the oral route has practical advantages and is at least as effective as nasal cannulas.
Bell
G D
GD
Department of Medicine, Ipswich Hospital, Suffolk, United Kingdom.
Quine
A
A
Antrobus
J H
JH
Morden
A
A
Burridge
S M
SM
Coady
T J
TJ
Lee
J
J
D016099:Endoscopy, Gastrointestinal; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000453:epidemiology / Q000517:prevention & control*; D008297:Male; D008874:Midazolam / Q000627:therapeutic use; D008875:Middle Aged; D010100:Oxygen / Q000008:administration & dosage* / Q000097:blood; D010102:Oxygen Inhalation Therapy; D011292:Premedication; D011446:Prospective Studies; D012189:Retrospective Studies
D008874:Midazolam; D010100:Oxygen